Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Page 1
Different patient versus provider perspectives on living with Cushing's disease.
Halstrom A, Lin IH, Lin A, Cohen M, Tabar V, Geer EB. Halstrom A, et al. Among authors: tabar v. Pituitary. 2024 Apr;27(2):141-150. doi: 10.1007/s11102-024-01381-4. Epub 2024 Feb 5. Pituitary. 2024. PMID: 38315244 Free PMC article.
'medical therapies/tumor control' for HCPs. CONCLUSIONS: CD patients experience long term symptoms and impaired QoL which may in part be due to a perception of lack of effective treatment options and little hope for improvement. Communicating experiences and care goals may …
'medical therapies/tumor control' for HCPs. CONCLUSIONS: CD patients experience long term symptoms and impaired QoL which may in part …
Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control.
Bander ED, Yuan M, Reiner AS, Panageas KS, Ballangrud ÅM, Brennan CW, Beal K, Tabar V, Moss NS. Bander ED, et al. Among authors: tabar v. Neurooncol Pract. 2021 Jan 21;8(3):278-289. doi: 10.1093/nop/npab005. eCollection 2021 Jun. Neurooncol Pract. 2021. PMID: 34055375 Free PMC article.
BACKGROUND: Adjuvant stereotactic radiosurgery (SRS) improves the local control of resected brain metastases (BrM). However, the dependency of long-term outcomes on SRS timing relative to surgery remains unclear. ...
BACKGROUND: Adjuvant stereotactic radiosurgery (SRS) improves the local control of resected brain metastases (BrM). However, the dependency …
Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
Bander ED, Yuan M, Carnevale JA, Reiner AS, Panageas KS, Postow MA, Tabar V, Moss NS. Bander ED, et al. Among authors: tabar v. Cancer. 2021 Jun 15;127(12):2062-2073. doi: 10.1002/cncr.33459. Epub 2021 Mar 2. Cancer. 2021. PMID: 33651913 Free PMC article.
However, breakthroughs in targeted and immunotherapies have improved long-term survival in those with advanced melanoma. Therefore, MBM presentation, prognosis, and the use of multimodality central nervous system (CNS)-directed treatment were reassessed. ...
However, breakthroughs in targeted and immunotherapies have improved long-term survival in those with advanced melanoma. Therefore, M …
Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01.
Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, Rosen S, Ramnarine K, Horn C, Fredrickson C, Wong K, Safford B, Kriks S, El Maarouf A, Rutishauser U, Henchcliffe C, Wang Y, Riviere I, Mann S, Bermudez V, Irion S, Studer L, Tomishima M, Tabar V. Piao J, et al. Among authors: tabar v. Cell Stem Cell. 2021 Feb 4;28(2):217-229.e7. doi: 10.1016/j.stem.2021.01.004. Cell Stem Cell. 2021. PMID: 33545080 Free PMC article.
We have generated midbrain dopamine neurons from human embryonic stem cells and manufactured large-scale cryopreserved dopamine progenitors for clinical use. After optimizing cell survival and phenotypes in short-term studies, the cell product, MSK-DA01, was subjected to a …
We have generated midbrain dopamine neurons from human embryonic stem cells and manufactured large-scale cryopreserved dopamine progenitors …
Long-term clinically relevant rodent model of methotrexate-induced cognitive impairment.
Berlin C, Lange K, Lekaye HC, Hopland K, Phillips S, Piao J, Tabar V. Berlin C, et al. Among authors: tabar v. Neuro Oncol. 2020 Aug 17;22(8):1126-1137. doi: 10.1093/neuonc/noaa086. Neuro Oncol. 2020. PMID: 32242229 Free PMC article.
METHODS: Here, we use a clinically relevant regimen of several cycles of methotrexate and leucovorin rescue to develop a model of chemotherapy-induced cognitive impairment, and investigate the in vivo long-term (16 mo) impact of high-dose systemic methotrexate on white mat …
METHODS: Here, we use a clinically relevant regimen of several cycles of methotrexate and leucovorin rescue to develop a model of chemothera …
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?
Jordan EJ, Lowery MA, Basturk O, Allen PJ, Yu KH, Tabar V, Beal K, Reidy DL, Yamada Y, Janjigian Y, Abou-Alfa GK, O'Reilly EM. Jordan EJ, et al. Among authors: tabar v. Clin Colorectal Cancer. 2018 Jun;17(2):e315-e321. doi: 10.1016/j.clcc.2018.01.009. Epub 2018 Feb 7. Clin Colorectal Cancer. 2018. PMID: 29496399 Free PMC article.
Overall survival for patients who had craniotomy (n = 4) was 11 months (range, 1-31 months), with 2 long-term survivors at 21 and 31 months, respectively. Four patients had leptomeningeal disease. ...
Overall survival for patients who had craniotomy (n = 4) was 11 months (range, 1-31 months), with 2 long-term survivors at 21 and 31 …
Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
Zacharia BE, DiStefano N, Mader MM, Chohan MO, Ogilvie S, Brennan C, Gutin P, Tabar V. Zacharia BE, et al. Among authors: tabar v. J Neurooncol. 2017 Sep;134(2):245-251. doi: 10.1007/s11060-017-2512-y. Epub 2017 May 27. J Neurooncol. 2017. PMID: 28551847 Review.
More patients are surviving long-term following a cancer diagnosis and as such are at risk for second malignancies. ...
More patients are surviving long-term following a cancer diagnosis and as such are at risk for second malignancies. ...
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
Kohutek ZA, Yamada Y, Chan TA, Brennan CW, Tabar V, Gutin PH, Yang TJ, Rosenblum MK, Ballangrud Å, Young RJ, Zhang Z, Beal K. Kohutek ZA, et al. Among authors: tabar v. J Neurooncol. 2015 Oct;125(1):149-56. doi: 10.1007/s11060-015-1881-3. Epub 2015 Aug 26. J Neurooncol. 2015. PMID: 26307446 Free PMC article.
Here, we investigated the incidence of and clinical variables associated with the development of radionecrosis and related radiographic changes after SRS for brain metastases in a cohort of patients with long-term follow up. 271 brain metastases treated with single-fractio …
Here, we investigated the incidence of and clinical variables associated with the development of radionecrosis and related radiographic chan …
14 results